- Home
- AMZE vs PMCB Comparison
AMZE vs PMCB Comparison
Compare AMZE & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMZE
- PMCB
- Stock Information
- Founded
- AMZE 2019
- PMCB 1996
- Country
- AMZE United States
- PMCB United States
- Employees
- AMZE N/A
- PMCB N/A
- Industry
- AMZE Beverages (Production/Distribution)
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMZE Consumer Staples
- PMCB Health Care
- Exchange
- AMZE Nasdaq
- PMCB Nasdaq
- Market Cap
- AMZE 6.6M
- PMCB 7.1M
- IPO Year
- AMZE 2021
- PMCB N/A
- Fundamental
- Price
- AMZE $0.30
- PMCB $1.02
- Analyst Decision
- AMZE
- PMCB
- Analyst Count
- AMZE 0
- PMCB 0
- Target Price
- AMZE N/A
- PMCB N/A
- AVG Volume (30 Days)
- AMZE 127.8K
- PMCB 9.9K
- Earning Date
- AMZE 05-20-2025
- PMCB 03-17-2025
- Dividend Yield
- AMZE N/A
- PMCB N/A
- EPS Growth
- AMZE N/A
- PMCB N/A
- EPS
- AMZE N/A
- PMCB 1.29
- Revenue
- AMZE $254,711.00
- PMCB N/A
- Revenue This Year
- AMZE N/A
- PMCB N/A
- Revenue Next Year
- AMZE N/A
- PMCB N/A
- P/E Ratio
- AMZE N/A
- PMCB $0.79
- Revenue Growth
- AMZE N/A
- PMCB N/A
- 52 Week Low
- AMZE $0.25
- PMCB $1.00
- 52 Week High
- AMZE $1.25
- PMCB $2.42
- Technical
- Relative Strength Index (RSI)
- AMZE N/A
- PMCB 41.38
- Support Level
- AMZE N/A
- PMCB $1.05
- Resistance Level
- AMZE N/A
- PMCB $1.14
- Average True Range (ATR)
- AMZE 0.00
- PMCB 0.07
- MACD
- AMZE 0.00
- PMCB 0.01
- Stochastic Oscillator
- AMZE 0.00
- PMCB 13.33
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.